The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bierer, B. E.
Right arrow Articles by Burakoff, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bierer, B. E.
Right arrow Articles by Burakoff, S. J.

The Journal of Immunology, Vol 144, Issue 3 785-789, Copyright © 1990 by American Association of Immunologists

ARTICLES

Partial deletions of the cytoplasmic domain of CD2 result in a partial defect in signal transduction

BE Bierer, RE Bogart and SJ Burakoff
Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.

CD2 (T11, the T cell erythrocyte receptor or the SRBC receptor), a nonpolymorphic 47- to 55-kDa glycoprotein, appears to play a role in T lymphocyte adhesion, signal transduction, and differentiation. Pairs of anti-CD2 mAb induce T cell proliferation, suggesting that CD2 may be an Ag-independent pathway of T cell activation. We have expressed the human CD2 and a number of cytoplasmic domain deletion mutants of CD2 in an Ag-reactive murine hybridoma. We have previously shown that a cytoplasmic domain deletion mutant, CD2 delta B, in which the carboxyl- terminal 100 amino acids have been deleted, is no longer capable of signaling through CD2. Here we have expressed a second cytoplasmic domain deletion mutant, CD2 delta S, in which the terminal 41 amino acids have been removed, including the region with greatest conservation between the mouse, rat, and human species. CD2 delta S+ hybridomas were able to respond to Ag and to LFA-3 plus an anti-CD2 mAb. Although the CD2 delta S+ hybridomas responded comparably to the wild-type CD2+ hybridomas to certain pairs of anti-CD2 mAb (e.g., MT110 + 9-1 mAb), these CD2 delta S+ hybridomas were markedly deficient in their ability to respond to other pairs of stimulatory anti-CD2 mAb (e.g., 9.6 + 9-1 mAb). These data suggest that the cytoplasmic domain may have several functional regions, as partial deletions of the cytoplasmic domain appear to result in partial defects in signal transduction.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. J. Nunes, M. A. A. Castro, C. M. Goncalves, M. Bamberger, C. F. Pereira, G. Bismuth, and A. M. Carmo
Protein Interactions between CD2 and Lck Are Required for the Lipid Raft Distribution of CD2
J. Immunol., January 15, 2008; 180(2): 988 - 997.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Carmo, M. A. A. Castro, and F. A. Arosa
CD2 and CD3 Associate Independently with CD5 and Differentially Regulate Signaling Through CD5 in Jurkat T Cells
J. Immunol., October 15, 1999; 163(8): 4238 - 4245.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Nishizawa, C. Freund, J. Li, G. Wagner, and E. L. Reinherz
Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation
PNAS, December 8, 1998; 95(25): 14897 - 14902.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Sunder-Plassmann and E. L. Reinherz
A p56lck-independent Pathway of CD2 Signaling Involves Jun Kinase
J. Biol. Chem., September 11, 1998; 273(37): 24249 - 24257.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.